Journal profile · PHARMACOLOGY & PHARMACY
Journal of Pharmacy & Pharmacognosy Research
ISSN 0719-4250 · Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA) · Chile
Journal of Pharmacy & Pharmacognosy Research: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 600; review about 8 weeks (community reports); 126 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of Pharmacy & Pharmacognosy Research is published by Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA) and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Natural Antidiabetic Agents Studies, Essential Oils and Antimicrobial Activity and Phytochemistry and Biological Activities, together about 24% of its articles. Its main subfields are Plant Science. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): PHARMACOLOGY & PHARMACY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Natural Antidiabetic Agents StudiesMedicine9.7%
- Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences7.4%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences6.9%
- Ethnobotanical and Medicinal Plants StudiesAgricultural and Biological Sciences6.6%
- Phytochemicals and Antioxidant ActivitiesMedicine5.8%
- Computational Drug Discovery MethodsComputer Science5.6%
- Pharmaceutical Practices and Patient OutcomesMedicine5.1%
- Diverse Scientific Research StudiesHealth Professions4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 2.5LetPub ·
- SJR 2026-06
- 0.27LetPub ·
- SNIP 2026-06
- 0.39LetPub ·
- h-index
- 27OpenAlex ·
- i10-index
- 116OpenAlex ·
- 2-year mean citedness
- 1.03OpenAlex ·
- Self-citation rate
- 20%LetPub ·
- Share of gold OA articles
- 97.14%LetPub ·
Volume
- Articles per year
- 177LetPub ·
Articles by year OpenAlex count · 929 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 76 | 76 | 8 |
| 2025 | 126 | 126 | 94 |
| 2024 | 155 | 155 | 265 |
| 2023 | 121 | 121 | 380 |
| 2022 | 106 | 106 | 697 |
| 2021 | 84 | 84 | 881 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 8 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 600 | No | CC BY-NC-ND | |
| LetPub | USD 600 | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Academic Association of Pharmaceutical Sciences from Antofagasta (ASOCIFA)
- Country or region
- Chile
- Language
- English, Spanish
- ISSN
- 0719-4250
- Official links
- Journal homepage ↗DOAJ
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Pharmacy & Pharmacognosy Research
What CAS zone is Journal of Pharmacy & Pharmacognosy Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Pharmacy & Pharmacognosy Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
How long does peer review take at Journal of Pharmacy & Pharmacognosy Research?
Authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Pharmacy & Pharmacognosy Research?
According to LetPub and DOAJ records, Journal of Pharmacy & Pharmacognosy Research is indexed in ESCI, Scopus and DOAJ.
Is Journal of Pharmacy & Pharmacognosy Research open access, and what is the APC?
Journal of Pharmacy & Pharmacognosy Research is a fully open-access journal. APC about USD 600.
Sources and updates
The facts on this page come from LetPub, DOAJ, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .